BioMotiv accelerates discoveries into medicines through a unique business platform that brings pharmaceutical expertise, aligned capital, and industry partners together to support inventors and portfolio companies.
BioMotiv partners closely with innovators in forming companies around breakthrough discoveries. These inventions are sourced principally from research institutions across the United States and United Kingdom. The BioMotiv portfolio includes small molecules and biologics targeting a wide variety of medical conditions.
Our leadership and portfolio teams are well-versed in translational science, with deep pharmaceutical experience having supported the advancement of numerous programs into clinical development and into the marketplace. This expertise guides the advancement of technologies being developed by the companies.
We have established strategic partnerships with contract research organizations, investment, and pharmaceutical partners to support technology development.
Efficient Operating Platform
BioMotiv provides an operating platform including business development, legal, financial, IT, and administrative support to enable companies to focus their attention and resources principally on their pharmaceutical programs.
Deep Business Networks
Through their careers, the company’s leadership team and advisory board members have developed broad relationships in the investment and pharmaceutical industries that are accessed for the benefit of BioMotiv companies.